Brian L. Burnette

647 total citations
26 papers, 269 citations indexed

About

Brian L. Burnette is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Geriatrics and Gerontology. According to data from OpenAlex, Brian L. Burnette has authored 26 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Geriatrics and Gerontology. Recurrent topics in Brian L. Burnette's work include Frailty in Older Adults (7 papers), Palliative Care and End-of-Life Issues (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Brian L. Burnette is often cited by papers focused on Frailty in Older Adults (7 papers), Palliative Care and End-of-Life Issues (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). Brian L. Burnette collaborates with scholars based in United States and Canada. Brian L. Burnette's co-authors include Aminah Jatoi, Antonio C. Wolff, Fengmin Zhao, Kathy D. Miller, Joseph A. Sparano, Bhuvaneswari Ramaswamy, Barbara Haley, P. Cheema, Cristina I. Truica and Melinda L. Telli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Brian L. Burnette

23 papers receiving 263 citations

Peers

Countries citing papers authored by Brian L. Burnette

Since Specialization

Citations

This map shows the geographic impact of Brian L. Burnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. Burnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. Burnette more than expected).

Fields of papers citing papers by Brian L. Burnette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian L. Burnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. Burnette. The network helps show where Brian L. Burnette may publish in the future.

Co-authorship network of co-authors of Brian L. Burnette

This figure shows the co-authorship network connecting the top 25 collaborators of Brian L. Burnette. A scholar is included among the top collaborators of Brian L. Burnette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian L. Burnette. Brian L. Burnette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fatigue, physical function, and the context of social vulnerability for older adults with cancer 2025 ·Journal of Geriatric Oncology ·(unknown), (unknown), (unknown), (unknown), Marie Flannery, Brian L. Burnette, (unknown), (unknown), Karen M. Mustian, Kian Ping Loh, Supriya G. Mohile, Christopher L. Seplaki, Nikesha Gilmore	0
2	Interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy: ECOG-ACRIN EA1211/DIRECT trial. 2024 ·Journal of Clinical Oncology ·(unknown), Constantine Gatsonis, Heather A. Jacene, Roisín M. Connolly, Brian L. Burnette, Erica Stringer-Reasor, Justin Romanoff, (unknown), Ciara C. O’Sullivan, Huong T. Le‐Petross, Courtney Lawhn-Heath, Vered Stearns, Amy M. Fowler, Shou‐Ching Tang, Karla A. Sepulveda, Angela DeMichele, David A. Mankoff, Antonio C. Wolff	0
3	Exploring the reliability and validity of clinically-relevant outcome measures for chemotherapy-induced peripheral neuropathy 2024 ·Supportive Care in Cancer ·Robert Knoerl, Michael B. Sohn, (unknown), Brian L. Burnette, (unknown), Karen M. Mustian, (unknown), Lynn R. Gauthier, Jennifer S. Gewandter	2
4	Personalized outcomes in neuropathic pain: a clinical relevance and assay sensitivity analysis from a randomized controlled trial 2024 ·Pain Medicine ·Karim R. Saab, (unknown), (unknown), Brian L. Burnette, (unknown), (unknown), Gary R. Morrow, Karen M. Mustian, Michael B. Sohn, Robert R. Edwards, Roy Freeman, Dale J. Langford, Michael P. McDermott, Jennifer S. Gewandter	1
5	Factors associated with Peaceful Acceptance of the Illness among Older Patients with Advanced Cancer 2023 ·Patient Education and Counseling ·Kah Poh Loh, Ronald M. Epstein, (unknown), Megan Wells, (unknown), Brian L. Burnette, Supriya G. Mohile	1
6	Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN): A proof-of-concept, placebo-controlled, randomized clinical trial (RCT). 2023 ·Journal of Clinical Oncology ·Jennifer S. Gewandter, (unknown), (unknown), (unknown), Joseph J. Guido, Brian L. Burnette, James D. Bearden, Mark Allen O’Rourke, Karen M. Mustian, Gary R. Morrow, Kathleen A. Sluka, Nimish Mohile	3
7	Communication About Fall Risk in Community Oncology Practice: The Role of Geriatric Assessment 2022 ·JCO Oncology Practice ·(unknown), Lianlian Lei, Huiwen Xu, Kah Poh Loh, Megan Wells, (unknown), Erika Ramsdale, Amber S. Kleckner, Karen M. Mustian, Richard F. Dunne, (unknown), James D. Bearden, Brian L. Burnette, Mary Whitehead, Supriya G. Mohile, Tanya M. Wildes	5
8	The relationship between comorbidities and other aging-related conditions among patients with advanced cancer 2022 ·Journal of Geriatric Oncology ·Amber S. Kleckner, Eva Culakova, (unknown), Jason Zittel, Brian L. Burnette, Thomas Bradley, Supriya G. Mohile	4
9	Caregiver-oncologist prognostic concordance, caregiving esteem, and caregiver outcomes 2022 ·Journal of Geriatric Oncology ·Kah Poh Loh, (unknown), Eva Culakova, Marie Flannery, Michael B. Sohn, Huiwen Xu, Sindhuja Kadambi, Allison Magnuson, Colin McHugh, Chandrika Sanapala, (unknown), Victor G. Vogel, Brian L. Burnette, Vincent Vinciguerra, Supriya G. Mohile, Paul R. Duberstein	1
10	Association of Oncologist-Patient Communication With Functional Status and Physical Performance in Older Adults 2022 ·JAMA Network Open ·(unknown), Lianlian Lei, Huiwen Xu, (unknown), Amita Patil, Kah Poh Loh, Erika Ramsdale, Allison Magnuson, Amber S. Kleckner, Tanya M. Wildes, Po‐Ju Lin, Karen M. Mustian, (unknown), Mary Whitehead, James D. Bearden, Brian L. Burnette, Jodi Geer, Supriya G. Mohile, Richard F. Dunne	7
11	The shared uncertainty experience of older adults with advanced cancer and their caregivers 2022 ·Psycho-Oncology ·Yingzi Zhang, Supriya G. Mohile, (unknown), Sally A. Norton, Kah Poh Loh, Sindhuja Kadambi, (unknown), Valerie Aarne Grossman, Victor G. Vogel, Brian L. Burnette, Thomas Bradley, Marie Flannery	6
12	Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment 2021 ·Journal of Geriatric Oncology ·Mostafa Mohamed, (unknown), Supriya G. Mohile, Huiwen Xu, Eva Culakova, Kah Poh Loh, Marie Flannery, Spencer Obrecht, Erika Ramsdale, Amita Patil, Richard F. Dunne, (unknown), Aram F. Hezel, Brian L. Burnette, (unknown), Jeffrey K. Giguere, Allison Magnuson	12
13	Life expectancy in older adults with advanced cancer: Evaluation of a geriatric assessment-based prognostic model 2021 ·Journal of Geriatric Oncology ·Jennifer L. Lund, Paul R. Duberstein, Kah Poh Loh, Nikesha Gilmore, Sandy Plumb, Lianlian Lei, Alexander P. Keil, Jessica Y. Islam, Laura C. Hanson, Jeffrey K. Giguere, Victor G. Vogel, Brian L. Burnette, Supriya G. Mohile	4
14	A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131 2021 ·Journal of Clinical Oncology ·Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette, Amyé Tevaarwerk, Sofia F. Garcia, Karen L. Smith, Erica L. Mayer, William M. Sikov, Eve T. Rodler, Lynne I. Wagner, Angela DeMichele, Joseph A. Sparano, Antonio C. Wolff, Kathy D. Miller	3
15	Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102 2018 ·Journal of Clinical Oncology ·Noah Kornblum, Fengmin Zhao, Judith Manola, Paula Klein, Bhuvaneswari Ramaswamy, Adam Brufsky, Phillip J. Stella, Brian L. Burnette, Melinda L. Telli, Della Makower, P. Cheema, Cristina I. Truica, Antonio C. Wolff, Gamini S. Soori, Barbara Haley, Timothy R. Wassenaar, Lori J. Goldstein, Kathy D. Miller, Joseph A. Sparano	141
16	Pharmacotherapy for adult acute lymphoblastic leukemia: an update from recent clinical trials and future directions 2012 ·Clinical Investigation ·Brian L. Burnette, Mrinal M. Patnaik, Mark R. Litzow	2
17	A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab 2011 ·Medical Oncology ·Timothy J. Poterucha, Brian L. Burnette, Aminah Jatoi	22
18	Prior Rituximab Exposure Does Not Appear to Affect Time to Treatment Failure After Radioimmunotherapy 2011 ·Blood ·Brian L. Burnette, Gregory A. Wiseman, Thomas M. Habermann, Stephen M. Ansell, Luis F. Porrata, David J. Inwards, Patrick B. Johnston, Ivana N. Micallef, William R. Macon, Thomas E. Witzig, Grzegorz S. Nowakowski	3
19	Parenteral nutrition in patients with cancer: recent guidelines and a need for further study 2010 ·Current Opinion in Supportive and Palliative Care ·Brian L. Burnette, Aminah Jatoi	3
20	Paraneoplastic polymyositis associated with mesothelioma: a brief report 2010 ·Community Oncology ·Steven R. Schuster, Brian L. Burnette, Giovanni De Petris, Catherine Harmon, John Camoriano, Helen J. Ross	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact